Impact of adjuvant chemotherapy in non-metastatic node positive bronchial neuroendocrine tumors (BNET).

被引：10
|
作者：
Westin, Gustavo Figueiredo Marcondes [1 ]
Alsidawi, Samer [1 ]
Leventakos, Konstantinos [1 ]
Halfdanarson, Thorvardur Ragnar [1 ]
Molina, Julian R. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.8533
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8533
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Impact of Adjuvant Chemotherapy in Non-Metastatic Node Positive Bronchial Neuroendocrine Tumors
    Westin, Gustavo
    Alsidawi, Samer
    Leventakos, Konstantinos
    Huffman, Brandon
    Halfdanarson, Thorvardur
    Molina, Julian
    PANCREAS, 2018, 47 (03) : 358 - 358
  • [2] Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancer
    Des Guetz, G.
    Uzzan, B.
    Morere, J. F.
    Perret, G.
    Nicolas, P.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (01):
  • [3] Effect of Adjuvant Chemotherapy After SBRT for Node Negative, Non-Metastatic Non-Small Cell Lung Cancer
    Copella, A.
    Deng, M.
    Handorf, E.
    Kumar, S. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E433 - E433
  • [4] TUMOUR:NODE RATIO IN NODE-POSITIVE, NON-METASTATIC BREAST CANCER
    Lim, S.
    Descallar, J.
    Sayaloune, P.
    Delaney, G.
    Papadatos, G.
    de Souza, P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 37 - 37
  • [5] Identifying Prohibitive Risk Factors for Resection in Non-Metastatic Pancreatic Neuroendocrine Tumors
    Heidenreich, B. M.
    Bader, J. M.
    O'Connor, V. V.
    Nelson, D. W.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S144 - S144
  • [6] Adjuvant Concurrent Chemoradiation and Chemotherapy for High Risk Non-Metastatic Endometrial Cancer
    Rajan, R.
    Kunheri, D. B.
    Tatineni, D. T.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S597 - S597
  • [7] MANAGEMENT OF NON-METASTATIC DUODENAL NEUROENDOCRINE TUMOURS
    Christou, N.
    Bouv-Hez, M. Mekkan
    Derbey, L.
    de Mestier, L.
    Lorenzo, D.
    Walter, T.
    Perrier, M.
    Cadiot, G.
    Goichot, B.
    Pracht, M.
    Lievre, A.
    Coriat, R.
    Valancot, S.
    Guimbaud, R.
    Carrere, N.
    Bacoeur-Ouzillou, O.
    Belleannee, G.
    Smith, D.
    Laboureau, S.
    Hescot, S.
    Julie, C.
    Teissier-Clement, M.
    Thereaux, J.
    Ferru, A.
    Evrad, C.
    Mathonnet, M.
    BRITISH JOURNAL OF SURGERY, 2023, 110
  • [8] Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands
    de Munck, L.
    Schaapveld, M.
    Siesling, S.
    Wesseling, J.
    Voogd, A. C.
    Tjan-Heijnen, V. C. G.
    Otter, R.
    Willemse, P. H. B.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (01) : 229 - 233
  • [9] Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands
    L. de Munck
    M. Schaapveld
    S. Siesling
    J. Wesseling
    A. C. Voogd
    V. C. G. Tjan-Heijnen
    R. Otter
    P. H. B. Willemse
    Breast Cancer Research and Treatment, 2011, 129 : 229 - 233
  • [10] Role of intraarterial cisplatin and intravenous adriamycin as neoadjuvant and adjuvant chemotherapy in non-metastatic osteosarcoma
    Mishra, A. N.
    Gill, J.
    Mishra, Y.
    ANNALS OF ONCOLOGY, 2017, 28
12345